Skip to content

Evaluation of Endoscopic Treatment of Zenker's Diverticulum Using LigaSure

Evaluation of Endoscopic Treatment of Zenker's Diverticulum Using the LigaSure Thermal Vessel Sealing System

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01739426
Acronym
ZENKER LS
Enrollment
10
Registered
2012-12-03
Start date
2013-03-31
Completion date
2015-06-30
Last updated
2015-10-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Zenker Diverticulum

Keywords

LigaSure V (TM)

Brief summary

The primary objective of this study is to evaluation the success of endoscopic treatment of Zenker's diverticulum using a LigaSure device (thermal fusion of vessels) via a measure of swallowing function at 12 months post-surgery.

Detailed description

Our secondary objectives are: A. To evaluate short-term (pain, fever, time to start of eating) and medium-term (weight, swallowing) post-operative parameters. B. To evaluate the prevalence of post-operative complications.

Interventions

DEVICERepair w/LigaSure

Surgical repair is carried out as normal except that a novel device is used: LigaSure V (TM) laparoscopic instrument (reference LS1500)

Sponsors

Centre Hospitalier Universitaire de Nīmes
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* The patient must have given his/her informed and signed consent * The patient must be insured or beneficiary of a health insurance plan * The patient is available for 12 months of follow-up * The patient has a Zenkers diverticulum as confirmed by a pharyngo-oesophagean transit test, regardless of van Overbeek classification

Exclusion criteria

* The patient is participating in another study * The patient is in an exclusion period determined by a previous study * The patient is under judicial protection, under tutorship or curatorship * The patient (or his/her person-of-trust) refuses to sign the consent * It is impossible to correctly inform the patient * The patient does not read french * The patient is pregnant * The patient is breastfeeding * The patients has a contraindication for a treatment necessary for this study, or for general anesthesia * The patent has a history of complications related to hemostasis * The preoperative checkup indicates potential for hemostasis related problems

Design outcomes

Primary

MeasureTime frame
Operational success according to the van Overbeek classification (yes/no)12 months
Change in Deglutition Handicap Index scorebaseline to 12 months

Secondary

MeasureTime frameDescription
Change in Temperature (°C)baseling to Day 1
Time until the patient restarts eating (hours)Day 1
Change in Deglutition Handicap Index scorebaseline to Day 3
Presence/absence of post-operative complicationsDay 0 (day of surgery)
Change in weightbaseline to 6-8 weeksChange in weight measured in kilograms
Change in visual analog scale for painbaseline to day 1Visual analog scale varying from 0 to 10

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026